SCOPUS 정보 검색 플랫폼

Chromatographia

Volumn 70, Issue 9-10, 2009, Pages 1417-1422

Simultaneous determination of ebastine and its active metabolite (carebastine) in human plasma using LC-MS-MS

(5) Feng, Sheng a Jiang, Ji a Wang, Peng a Liu, Dongyang a Hu, Pei a

a PEKING UNION MEDICAL COLLEGE HOSPITAL (China)

Author keywords

Carebastine; Column liquid chromatography tandem mass spectrometry; Ebastine; Human plasma

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; CAREBASTINE; EBASTINE; MECLOZINE; TERFENADINE;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG SELECTIVITY; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

EID: 72949096540 PISSN: 00095893 EISSN: 16121112 Source Type: Journal
DOI: 10.1365/s10337-009-1328-0 Document Type: Article

Times cited : (5)

References (7)

1
- 0036138172
- Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes
- DOI 10.1124/jpet.300.1.298
- H Takanori I Susumu M Masashi T Yoshiaki F Toshihiko M Hisashi K Tetsuya F Yoshihiko 2002 J Pharmacol Exp Ther 300 298 304 10.1124/jpet.300.1.298 (Pubitemid 34028540)
- (2002) Journal of Pharmacology and Experimental Therapeutics , vol.300 , Issue.1 , pp. 298-304
- Hashizume, T.¹ Imaoka, S.² Mise, M.³ Terauchi, Y.⁴ Fujii, T.⁵ Miyazaki, H.⁶ Kamataki, T.⁷ Funae, Y.⁸

2
- 0033007916
- A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis
- DOI 10.1034/j.1398-9995.1999.00984.x
- J Bousquet EM Gaudano AG Palma Carlos H Staudinger 1999 Allergy 54 562 568 10.1034/j.1398-9995.1999.00984.x 1:CAS:528:DyaK1MXktleqsrs%3D (Pubitemid 29301811)
- (1999) Allergy: European Journal of Allergy and Clinical Immunology , vol.54 , Issue.6 , pp. 562-568
- Bousquet, J.¹ Gaudano, E.M.² Carlos, A.G.P.³ Staudinger, H.⁴

3
- 0035811253
- 1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography
- DOI 10.1016/S0378-4347(00)00494-1, PII S0378434700004941
- M Matsuda Y Mizuki Y Terauchi 2001 J Chromatogr B Biomed Sci Appl 757 173 179 10.1016/S0378-4347(00)00494-1 1:CAS:528:DC%2BD3MXjtFCrsrs%3D (Pubitemid 32424470)
- (2001) Journal of Chromatography B: Biomedical Sciences and Applications , vol.757 , Issue.1 , pp. 173-179
- Matsuda, M.¹ Mizuki, Y.² Terauchi, Y.³

4
- 8844229574
- Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry
- DOI 10.1016/j.jchromb.2004.09.017, PII S1570023204007512
- W Kang K-H Liu J-Y Ryu J-G Shin 2004 J Chromatogr B 813 75 80 10.1016/j.jchromb.2004.09.017 1:CAS:528:DC%2BD2cXhtVSns7jI (Pubitemid 39535431)
- (2004) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.813 , Issue.1-2 , pp. 75-80
- Kang, W.¹ Liu, K.-H.² Ryu, J.-Y.³ Shin, J.-G.⁴

5
- 0003484310
- US Department of Health and Human Services Food and Drug Administration US Department of Health and Human Services: Rockville, MD
- US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: Bioanalytical Method validation, US Department of Health and Human Services: Rockville, MD, 2001. Website: http://www.fda.gov/cder/ guidance/index.htm
- (2001) Guidance for Industry: Bioanalytical Method Validation

6
- 72949122697
- State food and drug administration
- State food and drug administration, The Guidance of bioavailability and bioequivalence study technique for chemistry drug in human (No. [H]GCL2-1). 2005. Website: http://www.sda.gov.cn/gsz05106/08.pdf
- (2005) The Guidance of Bioavailability and Bioequivalence Study Technique for Chemistry Drug in Human (No. [H]GCL2-1)

7
- 14844313671
- Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry
- DOI 10.1016/j.clinbiochem.2004.11.007, LC Mass Spectrometry: Recent Development in Clinical Chemistry
- PJ Taylor 2005 Clin Biochem 38 328 334 10.1016/j.clinbiochem.2004.11.007 1:CAS:528:DC%2BD2MXit1Ciur8%3D (Pubitemid 40342863)
- (2005) Clinical Biochemistry , vol.38 , Issue.4 , pp. 328-334
- Taylor, P.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.